Feed ALMS
Summary
35 / 100 · Bulios Score
Valuation 47Growth -Profitability 20Quality 0Debt 100Stability 19
What speaks for it
- It holds more cash than debt: $63.7M against $36.4M.
What to watch
- The company made a loss over the last 12 months.
- Analysts expect revenue to fall by 73% this fiscal year.
- It passes only 2 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Revenue (USD)
202220232024202520262027
Diluted EPS (USD)
202220232024202520262027
- Analyst estimate
For the next fiscal year analysts expect revenue to fall by 73%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $439.0M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $502.3M
Debt $36.4M
Free cash flow over 12 months -$351.8M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 1
- Sell 0
Today's price within the analysts' price targets
Today's price $6.12 Average target $29.57
$6.12 $40
The average target of $29.57 is 383% above today's price. 88% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- License 72%
- Collaboration Revenue 28%
By region
The company reports no revenue by region.
License brings in 72% of revenue.
Segments in detail